Skip to main content
Clinical Trials/NCT03567343
NCT03567343CompletedNot Applicable

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of a Proprietary Spearmint Extract Blend, on Sleep in Healthy Men and Women

University of Arizona2 sites in 1 country105 target enrollmentStarted: May 18, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
105
Locations
2
Primary Endpoint
Sleep Diary- Sleep Latency

Study Overview

Brief Summary

This study seeks to observe the effects of a proprietary spearmint extract and green tea blend on sleep quality and duration. The study observes the effect of the supplement regarding sleep quality, and mental health.

Detailed Description

Sleep disturbance is common in adults and when it persists may result in chronic disease, excess health care utilization, mental disorders, health-risk behaviors, limitations of daily functioning, lost productivity, injury, and mortality (IOM 2006). An estimated 50-70 million adults in the United States have chronic sleep and wakefulness disorders (IOM 2006; Ram 2010) and many more adults report insufficient or deprived sleep. Data from 2014 indicates that approximately 35% of the US population is receiving insufficient sleep (Liu et al., 2016). This is alarming, since insufficient sleep is associated with cardiometabolic disease risk factors including weight gain, obesity, hypertension, diabetes, and inflammation (Grandner et al., 2016), as well as poor daytime functioning and many other outcomes (Grandner, 2017). Cognitive deficits are routinely seen in the laboratory, especially on the Psychomotor Vigilance Task (PVT) (Lim and Dinges, 2010). The National Institutes of Health suggests that adults aim for 7-8 h of sleep per night; however, approximately 28% of adults in the United States reported sleeping 6 h or less based on data from 2008 to 2010 (Schoenborn 2010).

A number of strategies are recommended to promote sleep quality and quantity, including a series of behavioral recommendations, such as keeping to a routine sleeping schedule, the timing of eating and physical activity in relation to bedtime, avoidance of stimulants, and maintaining a bedroom environment conducive to sleep (National Sleep Foundation 2015). Although, pharmacologic options are available to treat sleep disturbances, there is consumer interest in natural sleep remedies due to concerns with side effects, dependency, and the safety of prescription medications. The current study seeks observe the effects of a new proprietary blend containing spearmint and green tea extract. It will be the first randomized, double-blind, placebo controlled trial observing the effects of 30 days of 500 mg of a blend containing Spearmint extract and green tea on sleep when administered 30 minutes before bed. This study will utilize Fit-bit (San Francisco, California) (a tool whose use for evaluation of sleep is growing) for daily evaluation of sleep throughout the study in addition to polysomnography, considered by many researchers to be the gold standard for evaluation of sleep outcomes, at chosen timepoints.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
22 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Sleep Diary- Sleep Latency

Time Frame: Change from baseline after 30 days supplementation

Time it takes to fall asleep after the lights have been turned off in minutes (Weekly averages)

Fitbit - Rapid Eye Movement (REM) Sleep

Time Frame: Change from baseline after 30 days supplementation

Change in Rapid Eye Movement (REM) Sleep in minutes (Weekly averages)

Secondary Outcomes

  • Sleep Diary- Sleep Efficiency(Change from baseline after 30 days supplementation)
  • Sleep Diary - Objective Sleep Quality(Change from baseline after 30 days supplementation)
  • Fitbit - Total Sleep Time(Change from baseline after 30 days supplementation)
  • Perceived Stress Scale (PSS)(Change from baseline after 30 days supplementation)
  • The Center for Epidemiological Studies Depression Scale (CESD)(Change from baseline after 30 days supplementation)
  • Sleep Diary -Total Sleep Time(Change from baseline after 30 days supplementation)
  • Sleep Diary-Wake After Sleep Onset(Change from baseline after 30 days supplementation)
  • Fitbit- Light Sleep(Change from baseline after 30 days supplementation)
  • Profile of Mood States (POMS)(Change from baseline after 30 days supplementation)
  • Fitbit- Sleep Efficiency(Change from baseline after 30 days supplementation)
  • Fitbit- Deep Sleep(Change from baseline after 30 days supplementation)
  • The Insomnia Severity Index (ISI)(Change from baseline after 30 days supplementation)
  • Pittsburgh Sleep Quality Index (PSQI)(Change from baseline after 30 days supplementation)
  • Sustained Attention(Change from baseline after 30 days supplementation)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

MICHAEL A GRANDNER

Assistant Professor of Psychiatry, Psychology, and Medicine Director, Sleep & Health Research Program

University of Arizona

Study Sites (2)

Loading locations...

Similar Trials

Investigational Test of a New Sleep... | Clinical Trial